Salient Capital Advisors’s Sanofi SNY Stock Holding History

Salient Capital Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-39,168	Closed	-$1.86M	–	277
2015 Q3	$1.86M	Sell	39,168 -6,344	-14%	-$323K	0.05%	105
2015 Q2	$2.25M	Sell	45,512 -12,838	-22%	-$651K	0.04%	105
2015 Q1	$2.88M	Buy	58,350 +7,360	+14%	+$352K	0.05%	94
2014 Q4	$2.33M	Buy	+50,990	New	+$2.47M	0.05%	100
2014 Q2	–	Sell	-5,594	Closed	-$292K	–	236
2014 Q1	$292K	Buy	5,594 +649	+13%	+$32.9K	0.01%	192
2013 Q4	$265K	Buy	+4,945	New	+$255K	0.01%	185

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Salient Capital Advisors's SNY Position: Q4 2015 in Review

Salient Capital Advisors sold out of Sanofi (SNY) in Q4 2015, closing a stake of 39,168 shares — an estimated $1.86M sold.

Salient Capital Advisors first reported a position in SNY in Q4 2013 and held it in 6 quarters. The position peaked at $2.88M in Q1 2015. 477 funds tracked by Wall St. Rank hold SNY as of Q4 2015.

Salient Capital Advisors reported no remaining Sanofi position as of Q4 2015 after selling out during the quarter.
Salient Capital Advisors sold 39,168 Sanofi shares in Q4 2015, an estimated $1.86M.
Salient Capital Advisors first reported a position in Sanofi in Q4 2013 and held it in 6 quarters.
Salient Capital Advisors's Sanofi position peaked at $2.88M in Q1 2015.
477 funds tracked by Wall St. Rank held Sanofi as of Q4 2015.

Based on Salient Capital Advisors's 13F filing for Q4 2015, filed 11 Feb 2016.